Daniel Orbach
About
Daniel Orbach is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine.
According to data from OpenAlex, Daniel Orbach has authored 317 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Pulmonary and Respiratory Medicine, 118 papers in Surgery and 93 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Orbach's work include Sarcoma Diagnosis and Treatment (153 papers), Tumors and Oncological Cases (62 papers) and Soft tissue tumor case studies (43 papers). Daniel Orbach is often cited by papers focused on Sarcoma Diagnosis and Treatment (153 papers), Tumors and Oncological Cases (62 papers) and Soft tissue tumor case studies (43 papers). Daniel Orbach collaborates with scholars based in France, Italy and United Kingdom. Daniel Orbach's co-authors include Andrea Ferrari, Gianni Bisogno, Michela Casanova, Odile Oberlin, Véronique Minard‐Colin, Hervé J. Brisse, Gaëlle Pierron, Bernadette Brennan, Christophe Bergeron and Gian Luca De Salvo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.
In The Last Decade
Daniel Orbach
299 papers receiving 6.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Daniel Orbach France | 41 | 3.4k | 1.9k | 1.8k | 1.5k | 1.3k | 317 | 6.3k | ||
| Leonard H. Wexler United States | 48 | 4.2k 1.2× | 1.1k 0.6× | 2.2k 1.2× | 1.4k 0.9× | 1.3k 1.0× | 159 | 7.6k | ||
| Gianni Bisogno Italy | 48 | 5.2k 1.5× | 2.6k 1.4× | 2.4k 1.3× | 2.1k 1.4× | 1.8k 1.4× | 336 | 8.2k | ||
| Rita Alaggio Italy | 42 | 3.3k 1.0× | 1.5k 0.8× | 1.5k 0.8× | 1.4k 0.9× | 1.9k 1.5× | 269 | 6.2k | ||
| Richard B. Womer United States | 39 | 3.8k 1.1× | 1.1k 0.6× | 1.6k 0.9× | 1.4k 0.9× | 1.2k 0.9× | 111 | 6.1k | ||
| Uta Dirksen Germany | 38 | 3.6k 1.1× | 976 0.5× | 1.5k 0.8× | 938 0.6× | 685 0.5× | 190 | 5.8k | ||
| Paul S. Dickman United States | 29 | 3.4k 1.0× | 1.2k 0.7× | 1.6k 0.9× | 1.2k 0.8× | 1.1k 0.9× | 77 | 5.0k | ||
| A. Zoubek Austria | 35 | 4.7k 1.4× | 1.2k 0.7× | 1.6k 0.9× | 994 0.7× | 1.6k 1.2× | 101 | 6.6k | ||
| Bhaskar N. Rao United States | 41 | 3.1k 0.9× | 1.7k 0.9× | 1.3k 0.7× | 865 0.6× | 1.3k 1.0× | 136 | 4.6k | ||
| Moody D. Wharam United States | 53 | 5.8k 1.7× | 2.1k 1.1× | 2.4k 1.3× | 2.5k 1.6× | 1.9k 1.5× | 184 | 9.3k | ||
| Michael Paulussen Germany | 34 | 4.6k 1.3× | 1.5k 0.8× | 1.2k 0.6× | 1.3k 0.8× | 1.5k 1.1× | 86 | 5.8k |
Countries citing papers authored by Daniel Orbach
Since
Specialization
Citations
This map shows the geographic impact of Daniel Orbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Orbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Orbach more than expected).
Fields of papers citing papers by Daniel Orbach
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Daniel Orbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Orbach. The network helps show where Daniel Orbach may publish in the future.
Co-authorship network of co-authors of Daniel Orbach
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Orbach. A scholar is included among the top collaborators of Daniel Orbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Orbach. Daniel Orbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bisogno, Gianni, Julia Chisholm, Raquel Hladun, et al.. (2025). Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial. Journal of Clinical Oncology. 43(16). 1856–1862.
2.
Salvo, Gian Luca De, Paola Del Bianco, Véronique Minard‐Colin, et al.. (2024). Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram. Cancer. 130(13). 2351–2360.
3.
Blay, Jean‐Yves, Margaret von Mehren, Robin L. Jones, et al.. (2023). Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies. ESMO Open. 8(5). 101618–101618.
4.
Virgone, Calogero, Tal Ben Ami, Jelena Roganović, et al.. (2023). Age-related biological differences in children’s and adolescents’ very rare tumors. SHILAP Revista de lepidopterología. 2. 100027–100027.
5.
Orbach, Daniel, Hervé J. Brisse, Pablo Berlanga, et al.. (2023). Oral vinorelbine in young patients with desmoid-type fibromatosis. Tumori Journal. 109(5). 511–518.
6.
Ferrari, Andrea, Pablo Berlanga, Susanne A. Gatz, et al.. (2023). Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives. Cancer Management and Research. Volume 15. 1183–1196.
7.
Penel, Nicolas, Sylvie Bonvalot, Alexandra Meurgey, et al.. (2022). Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis. Clinical Cancer Research. 28(18). 4105–4111.
8.
Ferrari, Andrea, Susanne A. Gatz, Véronique Minard‐Colin, et al.. (2022). Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma. Cancers. 14(24). 6060–6060.
9.
Sparber‐Sauer, Monika, Daniel Orbach, Fariba Navid, et al.. (2021). Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. British Journal of Cancer. 124(10). 1637–1646.
10.
Sessa, Cristiana, Dominik T. Schneider, François Planchamp, et al.. (2020). ESGO–SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers. The Lancet Oncology. 21(7). e360–e368.
11.
Penel, Nicolas, Thomas Ryckewaert, & Daniel Orbach. (2019). Traitements systémiques des fibromatoses agressives chez l’adulte et l’enfant : niveau de preuve et questions en suspens. Bulletin du Cancer. 107(3). 375–380.
12.
Bisogno, Gianni, Gian Luca De Salvo, Christophe Bergeron, et al.. (2019). Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 20(11). 1566–1575.
13.
Fresneau, Brice, Daniel Orbach, Cécile Faure‐Conter, et al.. (2018). Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study. European Journal of Cancer. 95. 11–19.
14.
Brecht, Ines B., Angela De Paoli, Gianni Bisogno, et al.. (2018). Pediatric patients with cutaneous melanoma: A European study. Pediatric Blood & Cancer. 65(6). e26974–e26974.
15.
Schultz, Kris Ann P., Gretchen M. Williams, Junne Kamihara, et al.. (2018). DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clinical Cancer Research. 24(10). 2251–2261.
16.
Lee, Johanna H. van der, Willemijn B. Breunis, Daniel Orbach, et al.. (2017). Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. Cancer. 124(5). 1016–1024.
17.
Galmiche, Louise, Véronique Minard‐Colin, Martin Rachwalski, et al.. (2017). Melanotic neuroectodermal tumor of infancy (MNTI) of the head and neck: A French multicenter study. Journal of Cranio-Maxillofacial Surgery. 46(2). 201–206.
18.
Irtan, Sabine, Louise Galmiche, Caroline Elie, et al.. (2016). Recurrence of Solid Pseudopapillary Neoplasms of the Pancreas: Results of a Nationwide Study of Risk Factors and Treatment Modalities. Pediatric Blood & Cancer. 63(9). 1515–1521.
19.
Oudot, Caroline, Anne Sophie Defachelles, Véronique Minard‐Colin, et al.. (2013). Les tumeurs desmoïdes en pédiatrie : état des connaissances actuelles. Bulletin du Cancer. 100(5). 518–528.
20.
Williamson, Daniel, Edoardo Missiaglia, Aurélien de Reyniès, et al.. (2010). Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma. Journal of Clinical Oncology. 28(13). 2151–2158.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leonard H. Wexler Breakdown of academic impact, for papers by Gianni Bisogno Breakdown of academic impact, for papers by Rita Alaggio Breakdown of academic impact, for papers by Richard B. Womer Breakdown of academic impact, for papers by Uta Dirksen Breakdown of academic impact, for papers by Paul S. Dickman Breakdown of academic impact, for papers by A. Zoubek Breakdown of academic impact, for papers by Bhaskar N. Rao Breakdown of academic impact, for papers by Moody D. Wharam Breakdown of academic impact, for papers by Michael Paulussen